Pharmaceuticals
CVS blows past estimates, hikes outlook as insurance business outperforms
A screen displays the logo and trading information for CVS at the New York Stock Exchange, March 24, 2026. Jeenah Moon | Reuters CVS Health on Wednesday blew past first-quarter earnings and revenue estimates and raised its 2026 guidance, as its once-troubled insurance business showed improvement. CVS, which operates the nation’s largest pharmacy chain, sees […]
Read More
Novo Nordisk CEO: Aim is to expand weight-loss market in U.S.
Charlotte Reed speaks with Mike Doustdar, CEO of Novo Nordisk, after the Danish comapny hiked its 2026 full-year guidance on the back of increased expectations for GLP-1 product sales. Source
Read More
Novo Nordisk stock jumps 6% after drugmaker hikes forcast as Wegovy pill sales smash forecasts
People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in Copenhagen, Denmark, March 26, 2026. Tom Little | Reuters Novo Nordisk hiked its annual profit guidance on Wednesday, as the drugmaker said its Wegovy weight-loss pill performed better than expected in the first three months of the […]
Read More
FDA withdrew studies finding Covid, shingles vaccines were safe
The FDA blocked the publication of several studies supporting the safety of vaccines against Covid and shingles in recent months, a Health and Human Services Department spokesperson confirmed on Tuesday. It’s the latest effort by the Trump administration to challenge safe and effective shots in the U.S. and make them harder to access for some […]
Read More
Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth
Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. View Press | Corbis News | Getty Images Pfizer on Tuesday posted first-quarter earnings and revenue that topped estimates and reaffirmed its 2026 outlook, as its recently launched and acquired products showed growth. Older top-selling drugs, including its blood thinner […]
Read More
Major health insurers show signs of recovery – but a key test looms
Piotr Swat | SOPA Images | Lightrocket | Getty Images Major health insurers appear to be off to an encouraging start this year — but a crucial test for the sector is still ahead. Solid first-quarter results have helped lift investor sentiment, even as insurers continue to grapple with higher medical costs. Companies including UnitedHealth, […]
Read More
Supreme Court temporarily lifts mail ban on abortion pill mifepristone
In this photo illustration, A packet of Mifepristone is seen at Wyoming’s last abortion clinic, Wellspring Center March 10, 2025 in Casper, Wyoming. Natalie Behring | Getty Images The U.S. Supreme Court on Monday temporarily lifted a lower court’s ban on the abortion pill mifepristone being sent through the mail. The administrative stay of the […]
Read More
‘Bubble effect’: Weight loss drug fueled growth is putting the pharma sector at risk, report finds
Surging demand for weight loss and diabetes drugs leaves the pharmaceutical sector at risk from a “bubble effect” as profitability soars, new research suggests. Demand for the likes of Wegovy and Zepbound has driven research and development returns to their highest level in years, but a report published by Deloitte on Monday suggests this is […]
Read More
AstraZeneca stock falls after FDA panel votes against new cancer drug
Shares of AstraZeneca turned lower Friday after U.S. regulatory advisors voted against approving its experimental cancer drug. An advisory panel for the U.S. Food and Drug Administration late Thursday voted 6-3 against AstraZeneca’s oral drug camizestrant intended for the treatment of a type of breast cancer tumor, citing concerns around trial design. The FDA generally […]
Read More
FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list in win for the companies
The headquarters of the U.S. Food and Drug Administration in Silver Spring, Maryland, Nov. 4, 2009. Jason Reed | Reuters The Food and Drug Administration on Thursday proposed excluding the active ingredients in Novo Nordisk and Eli Lilly‘s blockbuster obesity and diabetes medications from the list of drugs that outsourcing facilities can use for compounding […]
Read More